These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34154346)

  • 1. Research and correlation analysis on the dripper contamination of carteolol hydrochloride eye drops.
    Wang YM; Ren YL; Xu J; Zhang XF
    Ann Palliat Med; 2021 Jun; 10(6):6779-6785. PubMed ID: 34154346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product].
    Yamamoto T;
    Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial contamination of drops and dropper tips of in-use multidose eye drop bottles.
    Høvding G; Sjursen H
    Acta Ophthalmol (Copenh); 1982 Apr; 60(2):213-22. PubMed ID: 6753455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial contamination of preservative free eye drops in multiple application containers.
    Rahman MQ; Tejwani D; Wilson JA; Butcher I; Ramaesh K
    Br J Ophthalmol; 2006 Feb; 90(2):139-41. PubMed ID: 16424520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
    Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP
    J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial contamination of multi-use ophthalmic solutions in Kenya.
    Nentwich MM; Kollmann KH; Meshack J; Ilako DR; Schaller UC
    Br J Ophthalmol; 2007 Oct; 91(10):1265-8. PubMed ID: 17475714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1% carteolol hydrochloride eyedrops: long-term experience in the treatment of chronic open-angle glaucoma].
    van Husen H
    Klin Monbl Augenheilkd; 1986 Dec; 189(6):491-5. PubMed ID: 3550260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
    Arai R; Fukamachi D; Monden M; Akutsu N; Murata N; Okumura Y
    Intern Med; 2021 Jan; 60(1):79-83. PubMed ID: 32830185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops.
    Eto R; Kawano H; Suzuki A; Akashi R; Ikeda S; Maemura K
    Intern Med; 2023 Sep; 62(17):2513-2516. PubMed ID: 36476545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial contamination of eye drops.
    Taşli H; Coşar G
    Cent Eur J Public Health; 2001 Aug; 9(3):162-4. PubMed ID: 11505742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shelf Life and Efficacy of Diagnostic Eye Drops.
    Hanssens JM; Quintana-Giraldo C; Jacques S; El-Zoghbi N; Lampasona V; Langevin C; Bouchard JF
    Optom Vis Sci; 2018 Oct; 95(10):947-952. PubMed ID: 30234830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial contamination of multiple-dose preservative-free hospital ophthalmic preparations in a tertiary care hospital.
    Chantra S; Hathaisaard P; Grzybowski A; Ruamviboonsuk P
    Adv Ophthalmol Pract Res; 2022; 2(1):100046. PubMed ID: 37846225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial Contamination and Antimicrobial Resistance in Use of Ophthalmic Solutions at the Department of Ophthalmology, Jimma University Specialized Hospital, Southwest Ethiopia.
    Tamrat L; Gelaw Y; Beyene G; Gize A
    Can J Infect Dis Med Microbiol; 2019; 2019():5372530. PubMed ID: 31178944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial Contamination of Multi-dose Eye Drops at Ophthalmology Department, University of Gondar, Northwest Ethiopia.
    Tsegaw A; Tsegaw A; Abula T; Assefa Y
    Middle East Afr J Ophthalmol; 2017; 24(2):81-86. PubMed ID: 28936051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion patterns and potential risks of beta-blocker ophthalmic drops in sports.
    Lin YA; Chiang WY; Chang WC; Kuo MT; Chen A; Hsu MC
    Drug Test Anal; 2023 Jan; 15(1):75-83. PubMed ID: 36097849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of fungal and bacterial contaminations of patient-used ocular drops.
    Feghhi M; Mahmoudabadi AZ; Mehdinejad M
    Med Mycol; 2008 Feb; 46(1):17-21. PubMed ID: 17885954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contact allergy to beta blockaders in eye drops: cross allergy?].
    Giordano-Labadie F; Lepoittevin JP; Calix I; Bazex J
    Ann Dermatol Venereol; 1997; 124(4):322-4. PubMed ID: 9739938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial contamination of multiple-use bottles of fluorescein ophthalmic solution.
    Kyei S; France D; Asiedu K
    Clin Exp Optom; 2019 Jan; 102(1):30-34. PubMed ID: 30058164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of microbial contamination of canine plasma eyedropper bottles following clinical use in canine patients.
    Strauss RA; Genschel U; Allbaugh RA; Sebbag L; Ben-Shlomo G
    Vet Ophthalmol; 2019 May; 22(3):222-228. PubMed ID: 29797413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial contamination of medications used to treat glaucoma.
    Geyer O; Bottone EJ; Podos SM; Schumer RA; Asbell PA
    Br J Ophthalmol; 1995 Apr; 79(4):376-9. PubMed ID: 7742288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.